Poniard Pharmaceuticals, Inc. (PARD)

[mlkrborn]

Poniard Pharma announces shareholders approve merger with Allozyne (PARD) 0.22 -0.04 : Co announced that its shareholders have approved proposals to complete the previously announced merger with Allozyne including the issuance of shares of Poniard common stock and resulting change of control of Poniard resulting from the merger and effecting a 1-for-40 reverse stock split of Poniard common stock.